Ashley Mansell

researcher

Ashley Mansell is …
instance of (P31):
humanQ5

External links are
P6178Dimensions author ID0715331140.19
P496ORCID iD0000-0002-6540-1281
P3829Publons author ID2884077
P1053ResearcherIDB-9553-2008
P1153Scopus author ID55855358300

P69educated atTrinity College DublinQ258464
Monash UniversityQ598841
P108employerHudson Institute of Medical ResearchQ28224129
P734family nameMansellQ21492110
MansellQ21492110
MansellQ21492110
P735given nameAshleyQ2655374
AshleyQ2655374
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q40826527A novel function of InIB from Listeria monocytogenes: activation of NF-kappaB in J774 macrophages.
Q37331618A type III effector antagonizes death receptor signalling during bacterial gut infection
Q38015963Adaptors in toll-like receptor signaling and their potential as therapeutic targets
Q35062754BTB-ZF transcriptional regulator PLZF modifies chromatin to restrain inflammatory signaling programs.
Q54644580Carbonylation caused by cigarette smoke extract is associated with defective macrophage immunity.
Q37220651Cloning, expression, purification, crystallization and preliminary X-ray crystallographic analysis of the TIR domain from the Brucella melitensis TIR-domain-containing protein TcpB.
Q27672321Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection
Q36985203Crystallization and X-ray diffraction analysis of the N-terminal domain of the Toll-like receptor signalling adaptor protein TRIF/TICAM-1.
Q38104149Dangerous liaisons between interleukin-6 cytokine and toll-like receptor families: a potent combination in inflammation and cancer
Q33321447Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia
Q46915545Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase.
Q35745385HIV Blocks Interferon Induction in Human Dendritic Cells and Macrophages by Dysregulation of TBK1
Q30244840Hero turned villain: NLRP3 inflammasome-induced inflammation during influenza A virus infection
Q34914125IL-1β and IL-18: inflammatory markers or mediators of hypertension?
Q43973968IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3.
Q34011006IRF7 in the Australian black flying fox, Pteropus alecto: evidence for a unique expression pattern and functional conservation
Q47555593In Vivo Infection Model of Severe Influenza A Virus
Q36959553Induction of memory cytotoxic T cells to influenza A virus and subsequent viral clearance is not modulated by PB1-F2-dependent inflammasome activation
Q42223932Innate IL-17A-producing leukocytes promote acute kidney injury via inflammasome and Toll-like receptor activation
Q40778672Internalin B activates nuclear factor-kappa B via Ras, phosphoinositide 3-kinase, and Akt.
Q54582048LPS hypersensitivity of gp130 mutant mice is independent of elevated haemopoietic TLR4 signaling.
Q52683283Life is so much easier for the sea urchin.
Q57168352Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines
Q36646684Lipopolysaccharide-deficient Acinetobacter baumannii shows altered signaling through host Toll-like receptors and increased susceptibility to the host antimicrobial peptide LL-37.
Q24291653Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction
Q40536979Mal interacts with tumor necrosis factor receptor-associated factor (TRAF)-6 to mediate NF-kappaB activation by toll-like receptor (TLR)-2 and TLR4.
Q27680670Mechanism of Bacterial Interference with TLR4 Signaling by Brucella Toll/Interleukin-1 Receptor Domain-containing Protein TcpB
Q24316185Mitochondrially localised MUL1 is a novel modulator of antiviral signaling
Q37433320MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses.
Q34618480MyD88 is a critical regulator of hematopoietic cell-mediated neuroprotection seen after stroke.
Q34298543Porphyromonas gingivalis lipopolysaccharide weakly activates M1 and M2 polarized mouse macrophages but induces inflammatory cytokines.
Q38718465Porphyromonas gulae Activates Unprimed and Gamma Interferon-Primed Macrophages via the Pattern Recognition Receptors Toll-Like Receptor 2 (TLR2), TLR4, and NOD2.
Q48575532Potential contribution of NF-kappaB in neuronal cell death in the glutathione peroxidase-1 knockout mouse in response to ischemia-reperfusion injury
Q41008506Pressor response to angiotensin II is enhanced in aged mice and associated with inflammation, vasoconstriction and oxidative stress
Q24318667Promyelocytic leukemia protein interacts with the apoptosis-associated speck-like protein to limit inflammasome activation
Q36990703Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition
Q41704940Recombinant production of functional full-length and truncated human TRAM/TICAM-2 adaptor protein involved in Toll-like receptor and interferon signaling
Q39113576Rotavirus NSP4 Triggers Secretion of Proinflammatory Cytokines from Macrophages via Toll-Like Receptor 2.
Q42206046STAT1 plays a role in TLR signal transduction and inflammatory responses.
Q98176751STAT3 serine phosphorylation is required for TLR4 metabolic reprogramming and IL-1β expression
Q57168339Sculpting the immune response to infection
Q39790110Stimulation of the interleukin-1 receptor and Toll-like receptor 2 inhibits hepatitis B virus replication in hepatoma cell lines in vitro
Q40113290Structural basis of TIR-domain-assembly formation in MAL- and MyD88-dependent TLR4 signaling
Q40328896Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation
Q37407517TIR-containing adaptors in Toll-like receptor signalling
Q39226435TLR ligands of ryegrass pollen microbial contaminants enhance Th1 and Th2 responses and decrease induction of Foxp3(hi) regulatory T cells
Q38830698TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target
Q52681554The Australian Toll-way gets the Nod--meeting report of TLROZ 2007: pattern recognition receptors in immunity and disease, Melbourne, Australia, 16-18th May 2007.
Q91760316The Single Nucleotide Polymorphism Mal-D96N Mice Provide New Insights into Functionality of Mal in TLR Immune Responses
Q36246129The TLR signaling adaptor TRAM interacts with TRAF6 to mediate activation of the inflammatory response by TLR4.
Q27687861The TLR signalling adaptor TRIF/TICAM-1 has an N-terminal helical domain with structural similarity to IFIT proteins
Q48203136The acetyltransferase HAT1 moderates the NF-κB response by regulating the transcription factor PLZF.
Q24293540The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway
Q40765797The serine protease inhibitor antithrombin III inhibits LPS-mediated NF-kappaB activation by TLR-4.
Q38956713Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients.
Q37825492Toll-like receptors as interferon-regulated genes and their role in disease
Q26746644Toll-like receptors: the swiss army knife of immunity and vaccine development
Q44765400Toll/IL-1 signaling is critical for house dust mite-specific helper T cell type 2 and type 17 [corrected] responses.

Search more.